CT-388, a dual GLP-1/GIP agonist, demonstrated over 22% weight loss at 48 weeks, offering a promising new treatment option for adults with obesity.

New research links chronic kidney disease to heart damage via harmful kidney-derived particles, highlighting opportunities for earlier detection, targeted therapies, and improved cardiovascular risk management in CKD patients.

PFAS exposure during pregnancy may increase gestational diabetes risk, underscoring environmental health concerns and the need for awareness, prevention strategies, and guidance during prenatal care.

The Brachiator mini-rail external fixation system enhances precision and efficiency in foot and ankle surgery, offering improved correction, comfort, and outcomes for complex fractures and deformities.

Depression in adolescents may alter recall of adverse childhood experiences, highlighting important links between mood, memory, and trauma that could influence mental health assessment and support strategies.

ANDROMEDA trial compares alpha and beta PSMA radioligand therapies with SBRT for recurrent oligometastatic prostate cancer, aiming to improve disease control and quality of life.

Circulating tumor DNA testing shows promise predicting relapse in high-risk breast cancer, enabling earlier intervention, monitoring, and treatment adjustments that could improve survival outcomes rates.

Selective radioactive iodine therapy for thyroid cancer shows improved survival, reinforcing personalized treatment approaches and guiding clinicians toward more targeted, effective care strategies.

Diverging state vaccine guidelines for children challenge federal recommendations, risking confusion for parents and providers, inconsistent coverage, and public health impacts as school season nears.

Mobile behavioral support from former smokers may improve smoking cessation rates, offering a scalable, peer-driven approach that complements existing programs and strengthens public health efforts to reduce tobacco use.